Wanli Lu
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Biotechnology top 5%
- Microbial Metabolism and Applications
- Marine Sponges and Natural Products
Papers in
-
- RNA and protein synthesis mechanisms 4
- Chemical Synthesis and Analysis 3
- Genomics and Phylogenetic Studies 3
-
- Microbial Natural Products and Biosynthesis 9
- Co-authors
- Taifo Mahmud (6 shared papers)Wei‐Cheng You (1 shared paper)Dongxin Lin (1 shared paper)Kai‐Feng Pan (1 shared paper)Lian Zhang (1 shared paper)Xiaoping Miao (1 shared paper)Niran Roongsawang (2 shared papers)Kevin A. Reynolds (4 shared papers)
- Journals
- ChemBioChem (2 papers)Journal of the American Chemical Society (2 papers)Organic Letters (2 papers)Clinical Rheumatology (1 paper)Medicine (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Wanli Lu
21 papers receiving 859 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 299
- Biotechnology 122
- Rheumatology 91
- Molecular Biology 383
- Organic Chemistry 151
Countries citing papers authored by Wanli Lu
This map shows the geographic impact of Wanli Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanli Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanli Lu more than expected).
Fields of papers citing papers by Wanli Lu
This network shows the impact of papers produced by Wanli Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanli Lu. The network helps show where Wanli Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanli Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 185 | |
| 2 | 2017 | 91 | |
| 3 | 2009 | 72 | |
| 4 | 2015 | 69 | |
| 5 | 2011 | 59 | |
| 6 | 2017 | 58 | |
| 7 | 2014 | 45 | |
| 8 | 2006 | 45 | |
| 9 | 2018 | 43 | |
| 10 | 2014 | 38 | |
| 11 | 2013 | 34 | |
| 12 | 2016 | 23 | |
| 13 | 2015 | 23 | |
| 14 | 1998 | 20 | |
| 15 | 2021 | 16 | |
| 16 | 2005 | 15 | |
| 17 | 2018 | 12 | |
| 18 | Egr1 deficiency disrupts dynamic equilibrium of chondrocyte extracellular matrix through PPARγ/RUNX2 signaling pathways. | 2018 | 9 |
| 19 | 2017 | 5 | |
| 20 | 2018 | 5 |
About Wanli Lu
Wanli Lu is a scholar working on Molecular Biology, Pharmacology, Biotechnology, Oncology and Organic Chemistry, having authored 21 papers that have together received 869 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (9 papers), RNA and protein synthesis mechanisms (4 papers), Microbial Metabolism and Applications (4 papers), Chemical Synthesis and Analysis (3 papers), Genomics and Phylogenetic Studies (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Marine Sponges and Natural Products (2 papers) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Pharmacology (299 citations), Biotechnology (122 citations), Rheumatology (91 citations), Molecular Biology (383 citations) and Organic Chemistry (151 citations). Wanli Lu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Taifo Mahmud, Wei‐Cheng You, Dongxin Lin, Kai‐Feng Pan, Lian Zhang, Xiaoping Miao, Niran Roongsawang, Kevin A. Reynolds, Papireddy Kancharla and Jane X. Kelly. Their work appears in journals such as ChemBioChem, Journal of the American Chemical Society, Organic Letters, Clinical Rheumatology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.